Aspen Pharmacare | APN - Interest Expense On Debt


Aspen Pharmacare reported ZAR631.5M in Interest Expense on Debt for its fiscal semester ending in June of 2024.





Interest Expense On Debt Change Date
Aspen Pharmacare ZAR 631.5M 301.5M Jun/2024
Cipla INR 140.3M 8.5M Dec/2025
Dr.Reddys Laboratories INR 944M 37M Dec/2025
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Kalbe Farma IDR 9.69B 689.63M Sep/2025
Life Healthcare ZAR 431M 107M Dec/2022
Netcare ZAR 439M 51M Dec/2022
Richter Gedeon HUF 7.5B 9.53B Sep/2024